TrialActa oncologica (Stockholm, Sweden)2025
Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
Pia J Heino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.